Triamcinolone Acetonide

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Triamcinolone Acetonide
Generic name: TRIAMCINOLONE ACETONIDE
Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 5873c78d-a9d4-49fc-95b8-5d4a368e9109
SPL ID: 3d287790-0065-44fb-a7e6-388ecd89e47b
Version: 3
Effective date: 2023-07-01
Source export date: 2026-10-12
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fb14b8f3d34b45230a84f851c029385f512adf3f002423a9b78d4f7ca626ecec/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:25:13

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 28 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	209535	derived:openfda.application_number
application number		ANDA209535	openfda.application_number
brand name		Triamcinolone Acetonide	openfda.brand_name
generic name		TRIAMCINOLONE ACETONIDE	openfda.generic_name
manufacturer name		Macleods Pharmaceuticals Limited	openfda.manufacturer_name
ndc	package	33342-329-30	openfda.package_ndc
ndc	package	33342-327-15	openfda.package_ndc
ndc	package	33342-327-80	openfda.package_ndc
ndc	package	33342-329-54	openfda.package_ndc
ndc	package	33342-329-80	openfda.package_ndc
ndc	package	33342-329-15	openfda.package_ndc
ndc	package	33342-328-15	openfda.package_ndc
ndc	product	33342-327	openfda.product_ndc
ndc	product	33342-329	openfda.product_ndc
ndc	product	33342-328	openfda.product_ndc
ndc11	package	33342032930	derived:openfda.package_ndc
ndc11	package	33342032780	derived:openfda.package_ndc
ndc11	package	33342032815	derived:openfda.package_ndc
ndc11	package	33342032980	derived:openfda.package_ndc
ndc11	package	33342032715	derived:openfda.package_ndc
ndc11	package	33342032954	derived:openfda.package_ndc
ndc11	package	33342032915	derived:openfda.package_ndc
rxcui		1014314	openfda.rxcui
rxcui		1085686	openfda.rxcui
rxcui		1085644	openfda.rxcui
spl id		3d287790-0065-44fb-a7e6-388ecd89e47b	id
spl set id		5873c78d-a9d4-49fc-95b8-5d4a368e9109	set_id
unii		F446C597KA	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS: The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.